Stay updated with breaking news from Bill skarnes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By studying iPSCs, we might be able to follow clues that lead to the genetic causes of Alzheimer’s and other dementias, paving the road for gene therapies. ....
Synthego, the genome engineering company, today announced the launch of Eclipse™, a new high-throughput cell engineering platform designed to accelerate drug discovery and validation by providing highly predictable CRISPR-engineered cells at scale through the integration of engineering, bioinformatics, and proprietary science. The launch of this unique CRISPR-based platform is driving the company s growing impact in biopharma R&D, reinforcing Synthego s position as the genome engineering leader. Synthego s Eclipse Platform Enables Scalable CRISPR-based Cell Engineering CRISPR-engineered cells have a wide range of applications in research and development across disease areas, including in neuroscience and oncology. Synthego created the Eclipse platform to enhance disease modeling, drug target identification and validation, and accelerate cell therapy manufacturing. ....